Comparison of Clinical Characteristics and Outcomes in Patients with STEMI in Croatia and Kosovo

Q3 Medicine
Koshi Rreze, S. Maja, Miličić Davor, Elezi Shpend
{"title":"Comparison of Clinical Characteristics and Outcomes in Patients with STEMI in Croatia and Kosovo","authors":"Koshi Rreze, S. Maja, Miličić Davor, Elezi Shpend","doi":"10.46619/JOH.2020.1-1006","DOIUrl":null,"url":null,"abstract":"INTRODUCTION The aim of our study was to compare clinical characteristics, risk factors, treatment modalities and medium-term outcomes in STEMI patients in two different countries, Croatia and Kosovo. MATERIAL AND METHODS The study included 77 consecutive patients from two regional hospitals, included in the STEMI network of University Clinical Center Zagreb, Croatia (group 1), and 75 STEMI consecutive patients treated in regional Hospital Gjakova, Kosovo (group 2). Standard laboratory tests were performed in both study groups. Patients were treated by the standard protocol of the country and hospital where they were treated. Immediate clinical outcomes and 6 months follow up results regarding MACE were compared. RESULTS There was no significant difference between groups in basic clinical characteristic except for diabetes mellitus, (x2 = 6.96, P = 0.008, P <0.01) and glycaemia control (U’ = 1530, P = 0.013).No significant difference between two groups in laboratory findings. There was a difference in percent of patients treated with primary PCI, 71 in gr 1 and 55 in group 2, reaching statistical significance (x2 test 8,261, p = 0.0045). In patients treated with PCI, there was no difference in “door to balloon time” (DTB) between groups. There was a remarkable difference in proportion of drug eluting stent (DES) implantation (3.5% in group 1, 29.1% in group 2 (x2 test 13.5, P = 0.0002).The difference partly derives from the relatively large number of balloon interventions in group 2. There was 2 deaths in group 1 in early hospital period, both during interventional procedure, one of the patients was in cardiogenic shock. There was no early mortality in group 2. In 6 month clinical follow up there were 3 deaths in group 2, all in patient with no revascularization, and no death in group 1. CONCLUSION We compared the clinical characteristics, treatment strategies and outcomes, in STEMI patients from two countries. After initial mortality, patients from Croatia had a better mid-term survival after recovery from their AMI compared to patients from Kosovo. Use of revascularization procedures was beneficial, but it was less often performed in Kosovo","PeriodicalId":50184,"journal":{"name":"Journal of Heart Valve Disease","volume":"41 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Heart Valve Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.46619/JOH.2020.1-1006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

INTRODUCTION The aim of our study was to compare clinical characteristics, risk factors, treatment modalities and medium-term outcomes in STEMI patients in two different countries, Croatia and Kosovo. MATERIAL AND METHODS The study included 77 consecutive patients from two regional hospitals, included in the STEMI network of University Clinical Center Zagreb, Croatia (group 1), and 75 STEMI consecutive patients treated in regional Hospital Gjakova, Kosovo (group 2). Standard laboratory tests were performed in both study groups. Patients were treated by the standard protocol of the country and hospital where they were treated. Immediate clinical outcomes and 6 months follow up results regarding MACE were compared. RESULTS There was no significant difference between groups in basic clinical characteristic except for diabetes mellitus, (x2 = 6.96, P = 0.008, P <0.01) and glycaemia control (U’ = 1530, P = 0.013).No significant difference between two groups in laboratory findings. There was a difference in percent of patients treated with primary PCI, 71 in gr 1 and 55 in group 2, reaching statistical significance (x2 test 8,261, p = 0.0045). In patients treated with PCI, there was no difference in “door to balloon time” (DTB) between groups. There was a remarkable difference in proportion of drug eluting stent (DES) implantation (3.5% in group 1, 29.1% in group 2 (x2 test 13.5, P = 0.0002).The difference partly derives from the relatively large number of balloon interventions in group 2. There was 2 deaths in group 1 in early hospital period, both during interventional procedure, one of the patients was in cardiogenic shock. There was no early mortality in group 2. In 6 month clinical follow up there were 3 deaths in group 2, all in patient with no revascularization, and no death in group 1. CONCLUSION We compared the clinical characteristics, treatment strategies and outcomes, in STEMI patients from two countries. After initial mortality, patients from Croatia had a better mid-term survival after recovery from their AMI compared to patients from Kosovo. Use of revascularization procedures was beneficial, but it was less often performed in Kosovo
克罗地亚和科索沃STEMI患者的临床特征和预后比较
本研究的目的是比较克罗地亚和科索沃两个不同国家STEMI患者的临床特征、危险因素、治疗方式和中期结局。材料和方法:本研究纳入来自克罗地亚萨格勒布大学临床中心STEMI网络的两家地区医院的77例连续患者(组1),以及在科索沃Gjakova地区医院治疗的75例连续STEMI患者(组2)。两个研究组均进行了标准实验室检查。病人按照接受治疗的国家和医院的标准方案接受治疗。比较MACE的即时临床结果和6个月随访结果。结果两组间除糖尿病(x2 = 6.96, P = 0.008, P <0.01)和血糖控制(U ' = 1530, P = 0.013)外,其他基本临床特征均无显著差异。两组实验室检查结果无显著差异。首次行PCI治疗的患者百分比,1组71例,2组55例,差异有统计学意义(x2检验8261,p = 0.0045)。在接受PCI治疗的患者中,两组之间的“门到球囊时间”(DTB)没有差异。两组患者药物洗脱支架(DES)植入率差异有统计学意义(1组为3.5%,2组为29.1%)(x2检验13.5,P = 0.0002)。这种差异部分源于第二组中相对较多的球囊干预。1组住院早期死亡2例,均在介入手术中死亡,其中1例为心源性休克。2组无早期死亡。临床随访6个月,2组死亡3例,均为无血运重建患者,1组无死亡病例。结论:我们比较了两个国家STEMI患者的临床特征、治疗策略和结局。与科索沃患者相比,克罗地亚患者在AMI恢复后的中期生存率高于初始死亡率。使用血运重建术是有益的,但在科索沃很少使用
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Heart Valve Disease
Journal of Heart Valve Disease 医学-心血管系统
CiteScore
1.00
自引率
0.00%
发文量
0
审稿时长
4-8 weeks
期刊介绍: The Journal of Heart Valve Disease (ISSN 0966-8519) is the official journal of The Society for Heart Valve Disease. It is indexed/abstracted by Index Medicus, Medline, Medlar, PubMed, Science Citation Index, Scisearch, Research Alert, Biomedical Products, Current Contents/Clinical Medicine. It is issued bi-monthly in one indexed volume by ICR Publishers Ltd., Crispin House, 12A South Approach, Moor Park, Northwood HA6 2ET, United Kingdom. This paper meets the requirements of ANSI standard Z39.48-1992 (Permanence of Paper).
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信